CYTK
CYTOKINETICS INC
Latest close $78.61 as of Aug 4, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 7 parsed filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Jul 8, 2026 filed · 8d Schedule 13G amendment | Earliest Schedule 13G amendment found | 5.2K | 12.00% | $85.19 | $84.88 | $78.61 |
| T. Rowe Price Investment Management CIK0001897612 | Dec 31, 2025 observed Feb 17, 2026 filed · 48d Schedule 13G amendment | Earliest Schedule 13G amendment found | 17.7M | 14.50% | $63.54 | $66.62 | $78.61 |
| State Street CIK0000093751 | Sep 30, 2025 observed Nov 10, 2025 filed · 41d Initial Schedule 13G | Initial Schedule 13G | 5.6M | 12.00% | $78.61 |